Molecular Mechanisms and Therapies of Colorectal Cancer 2.0

Colorectal cancer (CRC) is currently the third leading cause of cancer-related mortality. Transforming growth factor beta (TGF-β) signaling has been associated with CRC growth and metastasis due to its involvement in proliferation, epithelial-to-mesenchymal transition (EMT), and angiogenesis. The TG...

Full description

Saved in:

Bibliographic Details
Format:	Online
Language:	English
Published:	MDPI - Multidisciplinary Digital Publishing Institute 2024
Subjects:	CD44 CD44v6 monoclonal antibody colorectal cancer exosome cancer exosomal miRNA lncRNA carcinogenesis colon cancer reactive oxygen species sleep fragmentation KRAS NRAS BRAF microsatellite instability HER2 colorectal cancer (CRC) muscarinic acetylcholine receptor M3 (M3R) expression human colorectal cancer survival tissue microarray immune cell markers TIA-1 therapeutic target synchronous metastatic colorectal cancer liquid biopsy PIK3CA anti-EGFR anti-VEGF ABCG2 prognosis survival protein–protein interaction network immunohistochemistry qPCR immune checkpoint inhibition nivolumab ipilimumab metastatic colorectal cancer FOXO pictilisib mucinous colorectal adenocarcinomas molecular mechanisms ATPase autophagy hepatocytes liver NAADP biomarkers bafilomycin A1 Ca2+ store n/a KRAS G12C colorectal cancer mechanism of resistance KRAS inhibitor pocket thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues
Online Access:	ONIX_20240514_9783725809516_544
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Molecular Mechanisms and Therapies of Colorectal Cancer 2.0

Similar Items